Replies to post #195080 on Biotech Values

[biomaven0]

>>Are they using a proper comparative dose of Lyxumia

Yes, that's the standard maintenance dose.

[caravon]

mcbio,

At Morgan Stanley presentation, CLVS said they are looking for a c-MET partner for NSCLC.
I would suggest ARQL even with their not-good management.